# How Are Payers and Providers Optimizing Revenue Cycle Operations in 2026?

hcco.app · September 24, 2026

> The Direct Answer: Revenue Cycle Optimization Is a Shared Operating Problem Payer-provider revenue cycle optimization is the coordinated effort to...

## The Direct Answer: Revenue Cycle Optimization Is a Shared Operating Problem

Payer-provider revenue cycle optimization is the coordinated effort to reduce preventable payment friction, accelerate accurate claims, lower administrative expense, and improve cash flow without compromising claim accuracy or patient access. Providers traditionally focus on charges, coding, claim submission, denials, appeals, and patient balances, while payers focus on intake, adjudication, provider enrollment, claims processing, and payment integrity. The operating reality is more connected: every missing field, inconsistent identifier, delayed response, or mismatched policy can create work for both organizations. The September 25, 2026 question is therefore less about replacing one another’s systems and more about controlling the handoffs between them. Research cited by HealthLeaders Media frames automation as a factor that can raise healthcare costs when payers and providers deploy competing, poorly governed “bots.” At the same time, Healthcare IT Today describes AI-supported revenue cycle workflows as a means of optimizing the process from registration through payment. These findings are compatible: poorly supervised automation can multiply bad decisions, while governed automation can remove low-value work. Neither result is automatic.

**Also worth reading:** [How does AI governance in healthcare payer operations mitigate risk and ensure compliance while optimizing cost-containment?](https://hcco.app/knowledge/how_does_ai_governance_in_healthcare_payer_operations_mitigate_risk_and_ensure_compliance_while_optimizing_cost-containment.php) · [How can healthcare payers effectively optimize operations to reduce costs and improve care coordination?](https://hcco.app/knowledge/how_can_healthcare_payers_effectively_optimize_operations_to_reduce_costs_and_improve_care_coordination.php) · [What Does True CMS-0057-F Operational Readiness Actually Entail for Payers and Providers?](https://hcco.app/knowledge/what_does_true_cms-0057-f_operational_readiness_actually_entail_for_payers_and_providers.php)

A useful definition of revenue cycle optimization should include three outcomes: lower cost per transaction, faster cash conversion, and a stable or improving denial rate. If a system merely shifts work to a portal, call center, clearinghouse, or other organization, it has not created value. The same caution applies to claims processed automatically if accuracy declines and manual rework rises. The objective is not the highest possible automation rate; it is the lowest reliable cost of resolving each financial event. In a mature operating model, both sides measure the same exceptions, use common definitions, and assign responsibility for fixing their originating errors. This is especially important for B2B healthcare organizations that combine cost-containment goals with care-coordination duties, because financial friction can ultimately affect prior authorizations, scheduling, member engagement, and continuity of care.

## Where Costs Actually Accumulate Across the Revenue Cycle

Revenue cycle costs arise before a claim is submitted and often persist after payment reaches the provider. A patient’s coverage may be unknown at registration, an authorization may lack the clinical detail required for review, or a provider record may not match the payer’s enrollment file. These failures become staffing tasks, delayed bills, denied claims, and repeated patient contacts. A HealthLeaders Media analysis of the payer-provider automation contest argues that disconnected bots can make the exchange less efficient rather than removing the underlying problem. The practical lesson is to trace total effort rather than count each application’s apparent speed. An intake platform that saves ten minutes per call but creates three eligibility follow-ups may increase total cost.

The financial exposure is measurable through denial rates, days in accounts receivable, cost to collect, rework hours, and aging by payer. A 1% change in denial rate can have a large dollar effect for a large health system, but a low percentage is not automatically good: some organizations achieve it by delaying submission or appeal deadlines. Conversely, a high initial denial rate may reveal an opportunity rather than poor provider performance. Payers should separate correctable data defects from clinical or contract disputes, while providers should distinguish carrier processing rules from internal submission errors. TechTarget’s reporting connects revenue cycle AI and independent dispute resolution activity with a reported 9% medical cost trend; that relationship should not be presented as proof that either one caused the entire increase. Cost trend also reflects utilization, contract pricing, acuity, and service mix. Technology is one control among several.

A useful accounting method assigns each delay to its originating organization and calculates the avoidable labor, interest expense, and service cost together. For example, an eligibility response that arrives after registration may force a registration specialist to update coverage manually, a financial-clearance employee to revisit the case, and a patient to be contacted again. Counting only one interaction understates the burden. Shared reporting makes these handoffs visible and gives both parties a reason to prioritize root-cause fixes. It also prevents a superficially attractive automation project from becoming a recurring expense with little operational return.

## How AI Changes the Work, and When It Makes Things Worse

AI can assist with document classification, coding suggestions, eligibility checks, prior-authorization routing, denial prediction, appeal drafting, patient outreach, and payment posting. It can also identify patterns across millions of transactions that are difficult for staff to see consistently. Menlo Ventures’ 2025 State of AI in Healthcare analysis and other market research describe continued enterprise interest in healthcare AI, but adoption does not establish clinical accuracy, financial return, or safe governance. Providers should not assume that higher autonomous processing volume is better. Anthropic’s healthcare guidance, for example, highlights the need to evaluate model performance and use conditions rather than treating a general-purpose model as a finished healthcare product.

Automation can increase cost when rules conflict, models are trained on historically biased data, or vendors measure completion rather than correct resolution. A denial-management bot may draft an appeal that repeats unsupported information, while a voice agent may confidently collect the wrong insurance information. In a two-sided workflow, a provider’s generated appeal can trigger a payer’s automated review, which can generate another response, creating a costly exchange that appears productive in activity reports. Health IT Today’s emphasis on end-to-end workflow optimization is therefore more informative than any single AI feature. Human reviewers should remain available for ambiguous cases, high-dollar claims, adverse decisions, and appeals involving clinical judgment.

Governance should specify the action, the evidence, the permitted confidence level, and the escalation rule. For a payment-posting model, the relevant question may be whether the transaction matches the remittance advice. For a coding suggestion, it may be whether the documentation supports the proposed code. For an outbound call, it may be whether the agent obtained explicit consent, confirmed identity, and recorded the response accurately. A model that is 98% accurate on routine tasks can still create substantial review volume at high volume, while a 90%-accurate model may be unacceptable for clinical authorization decisions. Baselines, exception sampling, and rollback procedures matter more than promotional accuracy percentages.

## A Practical Operating Model for Payers and Providers

The first step is to establish a small set of shared measures. At minimum, these should include clean-claim rate, initial denial rate, denial appeal rate, days in accounts receivable, eligibility resolution time, authorization turnaround time, cost per claim, and patient-contact burden. A 95% clean-claim rate can be a reasonable internal target, but it should not be copied blindly: the definition of a clean claim, the service mix, and the payer mix may differ. The 2026 provider EHR IT consulting benchmark summarized by Newswire.com describes a shift from replacement-led projects toward optimization, workflow redesign, and measurable installed-base value. That is relevant because many organizations already have authorization, EHR, billing, and clearinghouse systems; adding another disconnected tool can worsen the problem.

The second step is to map exceptions rather than automate the happy path. Identify the five or ten most common causes of delay, quantify their financial effect, and determine which are provider-controlled, payer-controlled, jointly controlled, or outside the organization’s control. Shared escalation agreements should specify response windows, evidence requirements, and ownership. A payer that cannot resolve a network dispute within 10 business days should not expect a provider to keep an account open indefinitely; a provider that omits required authorization evidence should not expect an exception queue to compensate. Clear service expectations turn “bad actors” into measurable process failures and make vendor or partner conversations more productive.

The third step is to pilot one workflow with a defined baseline and a stop condition. For example, test automated eligibility verification on a limited payer network for eight to twelve weeks, measuring staff minutes, correction rates, patient wait time, and downstream denials. A pilot should be considered successful only if the total cost, including review and remediation, falls while accuracy remains within the agreed threshold. The fourth step is to expand gradually and to retire redundant tasks. If a portal previously required a call, the new process should remove the portal interaction rather than preserve both. A McKinsey & Company discussion of US healthcare priorities also points to persistent operational pressures, including workforce constraints and the need to modernize infrastructure. Revenue cycle work should therefore be connected to broader transformation, not treated as a narrow back-office experiment.

## Comparing Build, Buy, and Shared-Service Options

Most organizations will combine options rather than choose one exclusively. The central comparison is not whether commercial software is better than internal development; it is which layer needs differentiation, and where control of data and workflow matters most. A platform can be appropriate for eligibility, document intake, coding assistance, or denial categorization, while an internal team may be better positioned to maintain payer-specific rules and local clinical context. Outsourced teams can handle high-volume, repetitive work but may be less effective for disputes requiring negotiation or patient-specific clinical judgment. The table below illustrates the tradeoffs without implying that one model fits every payer or provider.

| Feature | Option A: Commercial platform | Option B: Internal build or extension | Option C: Shared service or managed operation |
| --- | --- | --- | --- |
| Time to initial deployment | Often weeks to a few months | Often several months for governed production use | Often weeks, depending on staffing and integration |
| Control of payer-specific rules | Usually configurable within vendor limits | Highest direct control | Depends on contract and retained expertise |
| Upfront cost | Integration, security review, and configuration | Engineering, data engineering, testing, and support | Contract fees, transition cost, and oversight |
| Ongoing operating burden | Vendor maintenance plus exception handling | Internal maintenance and model governance | Provider and payer retain governance responsibility |
| Best fit | Standardized, high-volume workflows | Differentiated rules or close system integration | Lean teams needing a transitional operating layer |

Pricing should be evaluated on total cost rather than license cost alone. A subscription might be priced per provider, facility, claim, transaction, user, or module, with implementation, interface work, storage, voice usage, and support billed separately. A low per-claim price can be more expensive than a higher subscription if the system produces appeals, reprocessed claims, or additional patient calls. Compare a three-year total-cost scenario, including integration, human review, and the internal labor saved. Ask whether prices rise when volume grows, how many environments are included, and what happens if the organization fails to meet usage assumptions. Vendor consolidation can reduce administrative burden, but a contract that locks the organization into one workflow should be evaluated against the cost of escaping that workflow later.

## Common Mistakes That Turn Optimization Into New Cost

The most common mistake is optimizing a local queue. Staff may become faster at submitting a claim, while the payer becomes slower at answering an appeal, or a portal may reduce the average call while increasing unresolved cases. Another error is treating a historical denial pattern as a stable rule. Payer policies, code edits, software releases, and contract terms change, so automation needs ownership and scheduled revalidation. McKinsey & Company’s forward-looking healthcare analysis is useful for strategic context, but it does not replace organization-specific operational measurement.

A second mistake is launching with incomplete identifiers. A claim that lacks a member ID, provider number, date of birth, or authorization reference may travel through several automated systems before anyone can identify the defect. Clean-claim percentages should be accompanied by data-quality sampling because a clean claim can still contain an error that passes every structural check. A third mistake is measuring staff time without measuring rework. Removing a task from one employee’s queue may simply move it to another team, an outsourced vendor, or the patient. The 2008 interoperability reference in the research context is old, but the underlying issue remains: information exchange depends on consistent data, agreed responsibilities, and technically reliable interfaces.

A fourth mistake is failing to include patients in the workflow. Automated outreach that sends unreadable messages, does not offer a working alternative, or makes payment difficult may reduce contact-center volume at the expense of collections and trust. A fifth mistake is assuming a longer project will automatically produce a better result. Bain’s analysis of healthcare IT investment warns that the “SaaSpocalypse” fear is not a substitute for disciplined portfolio management; software spending should be tied to operational outcomes and renewal decisions. Executive sponsors should require a monthly review of cost, accuracy, speed, and exceptions, with the authority to pause a deployment that creates net rework. This is more useful than celebrating the number of automated transactions.

## When to Act, and What Thresholds to Use

Act now when a financial problem is visible, measurable, and recurring, even if a major system replacement is not yet justified. A provider may have denied claims aging beyond 90 days, authorization work exceeding 30% of a team’s capacity, or patient balances increasing faster than collections. A payer may have provider disputes consuming more than 20% of an appeals unit’s workload, or enrollment corrections requiring repeated manual research. These thresholds are operating prompts rather than universal rules; the correct level depends on claim volume, dollar value, staffing, and service commitments. The key is to set a threshold before a crisis creates urgency.

A useful trigger is a repeated exception that appears in at least three consecutive monthly reviews and has a defined financial owner. Another is a turnaround target that is missed by more than 20% for two reporting periods. A third is an integration error rate above 2% for a new interface, provided that the denominator is stable and the severity of errors is considered. For a new vendor, pilot for at least 90 days when feasible, and use a representative sample across major payers, facilities, and claim types. If the result depends on one unusually clean payer or one low-risk service line, the pilot is not enough to justify enterprise rollout.

Timing also depends on contract and regulatory commitments. Organizations should review renewal dates, data-processing terms, security requirements, change-control obligations, and implementation capacity before committing to a platform. The 2026 EHR benchmark’s emphasis on measurable installed-base value suggests that improving existing workflows may be more practical than replacing everything. Bain’s investment analysis and Healthcare IT Today’s workflow discussion both support a disciplined approach, but neither can tell an organization when a particular purchase is economical. Leadership should document expected savings, expected adoption, and the maximum acceptable integration cost. If the business case cannot state those numbers in plain language, the project is not ready for broad deployment.

## The Best Path Forward for 2026 and Beyond

The strongest payer-provider strategy is cooperative measurement with clear accountability. Start by naming the shared financial outcomes, establish a baseline, and agree on definitions that both sides can reproduce. Automate only after the underlying workflow is understood, and use AI where its speed or pattern detection creates measurable value rather than simply because it is available. Keep humans responsible for clinical judgment, disputed facts, adverse decisions, and patient-impacting exceptions. This approach supports the cost-containment goal while preserving the data quality needed for care coordination.

Success should be judged after at least one full seasonal cycle, because utilization, staffing, and payer processing can change over time. A 2026 deployment that lowers administrative cost by 8% but increases denied dollars may be worse than a slower program that lowers total rework by 15%. The target should include cash, cost, accuracy, patient burden, and service capacity. That is a more credible standard than a headline claiming that AI will solve revenue cycle pressure. The research context shows strong interest in healthcare analytics, AI, and SaaS, but market growth does not guarantee operational savings.

For payers and providers, the practical decision is to move from isolated tools to a managed operating system of exceptions. Select partners that can exchange data, explain decisions, support audit trails, and meet security and service requirements. Reassess the vendor portfolio annually, retire unused modules, and require evidence that each system reduces total effort. The organizations that do this well will not necessarily have the most bots; they will have fewer unresolved handoffs, faster reliable payments, and more capacity for the clinical and member work that revenue cycle operations are meant to support.

## Quick answers

### What is payer-provider revenue cycle optimization?

It is the coordinated improvement of registration, authorization, claims, denials, appeals, payment, and patient-account processes across a payer and its provider network. The goal is to lower avoidable administrative cost and accelerate accurate payment, not merely increase automated transaction volume.

### How can AI reduce payer-provider revenue cycle costs?

AI can classify documents, check coverage, suggest coding, route denials, draft appeals, and support patient outreach. Savings are credible only when the organization measures total labor, rework, accuracy, and downstream denials after implementation.

### What is a good initial clean-claim rate?

A 95% target can be a useful starting point for some organizations, but it is not a universal standard. The target should reflect specialty mix, payer requirements, claim volume, and how cleanly the organization defines and measures a clean claim.

### Should healthcare organizations build or buy revenue cycle software?

Commercial platforms can shorten deployment for standardized workflows, while internal development can provide greater control over payer-specific rules. Many organizations use both, comparing three-year total cost, integration effort, governance, and the ability to change workflows.

### When should a payer or provider start an optimization project?

Start when a recurring problem has a measurable cost, a named owner, and enough volume to justify a controlled pilot. Repeated missed turnaround targets, rising rework, or denied claims aging beyond internal service thresholds are reasonable prompts, but the specific threshold should be set from the organization’s own baseline.

Canonical: https://hcco.app/knowledge/how_are_payers_and_providers_optimizing_revenue_cycle_operations_in_2026.php
Markdown: https://hcco.app/knowledge/how_are_payers_and_providers_optimizing_revenue_cycle_operations_in_2026.php/index.md